Dr. Nancy J. Anderson This is Me
View Title...
Loma Linda University Medical Center
Loma Linda, California
Please Note:
This profile was automatically generated using 139 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 139 references found on the Internet. This information has not been verified. Learn more...
Employment History
View...View all 139 references Web References
-
1. www.llumc.com
www.llumc.com/services/dermato - [Cached]Published on: 1/31/2008 Last Visited: 1/31/2008
Nancy Anderson, MD Residency Program Director, Medical Dermatology -
2. San Bernardino Support Group
support.psoriasis.org/sanberna - [Cached]Published on: 11/17/2006 Last Visited: 12/1/2006
Dr. Nancy Anderson, Dermatologist at Loma Linda University will be presenting a talk on "Long-Term Options in The Treatment of Psoriasis". -
3. Newswise
www.newswise.com/articles/view - [Cached]Published on: 7/29/2004 Last Visited: 7/29/2004
Speaking at ACADEMY '04, the American Academy of Dermatology's summer scientific session in New York, dermatologist Nancy J. Anderson, M.D., a professor of dermatology and residency director at Loma Linda University in Loma Linda, Calif., presented new research on the effectiveness of topical immunomodulators for treating vitiligo, psoriasis and allergic contact dermatitis.
...
"Short-term and long-term studies of both pimecrolimus and tacrolimus show that both medications are safe and effective for eczema patients of all ages, even infants," said Dr. Anderson. "Being able to treat infants as young as three months old in studies is an important development, as approximately 10 percent to 20 percent of all infants have eczema and many may require long-term or even lifelong treatment for their condition. However, presently they are FDA-approved for children age 2 and older."
In addition, Dr. Anderson explained that pimecrolimus and tacrolimus are being studied as viable new treatment options for a number of inflammatory skin diseases.
...
"Since this study involved a forced exposure to nickel and in real life patients are oftentimes re-exposed to allergens, volunteers were intermittently exposed to the metal allergen during treatment," explained Dr. Anderson.
...
"Topical immunomodulators are revolutionizing how dermatologists treat skin conditions," said Dr. Anderson.

